Eric Daar, M.D.
A highly regarded clinician/researcher, Dr. Daar is a well-traveled lecturer on the management of HIV infection and a regular presenter at the world's most important HIV-related conferences. Scores of his studies have been published in peer-reviewed journals, and he has authored many chapters and clinical reviews in HIV publications. Dr. Daar is a former associate editor of Clinical Infectious Diseases, currently serves on the editorial board of the journals AIDS and Current HIV/AIDS Reports, and is a peer reviewer for more than 20 medical journals, including the Journal of the American Medical Association, Journal of Infectious Diseases and the Journal of Acquired Immunodeficiency Syndromes.
Dr. Daar has remained true to Los Angeles, his native town: Aside from a four-year sojourn to Washington, D.C., where he earned his medical degree from Georgetown University School of Medicine, Dr. Daar has spent most of his life in the City of Angels. He earned his undergraduate degree from the University of California-Los Angeles, and once he completed his medical education, he returned to UCLA's Cedars-Sinai Medical Center for his internship, residency and fellowship. He lives just outside of Los Angeles with his wife and their four sons.
You can learn much more about Dr. Daar in this exclusive interview at The Body. We interviewed Dr. Daar in 2005, after he became one of 10 physicians to receive The Body's inaugural HIV Leadership Award for his outstanding years of service to the HIV community.
Dr. Daar has received research support from Abbott, Bristol-Myers Squibb Company (BMS), Gilead Sciences, Inc., GlaxoSmithKline, Merck & Co., Monogram Biosciences, Inc., Schering-Plough Corporation and Serono Laboratories, Inc.
Dr. Daar has served as a consultant or adviser for Abbott, Boehringer Ingelheim (BI), BMS, Gilead, Monogram, Pfizer, Inc., and Serono.
Dr. Daar has received honoraria from Abbott, BI, BMS, Gilead, Glaxo, Merck, Monogram, Serono, Tibotec BVBA and Virco BVBA.